Curcumin as a Potential Therapeutic Agent in Certain Cancer Types

Cureus. 2022 Mar 3;14(3):e22825. doi: 10.7759/cureus.22825. eCollection 2022 Mar.

ABSTRACT

Cancer is a devastating disease condition and is the second most common etiology of death globally. After decades of research in the field of hematological malignancies and cellular therapeutics, we are still looking for therapeutic agents with the most efficacies and least toxicities. Curcumin is one of the cancer therapeutic agents that is derived from the Curcuma longa (turmeric) plant, and still in vitro and in vivo research is going on to find its beneficial effects on various cancers. Due to its potency to affect multiple targets of different cellular pathways, it is considered a promising agent to tackle various cancers alone or in combination with the existing chemotherapies. This review covers basic properties, mechanism of action, potential targets (molecules and cell-signaling pathways) of curcumin, as well as its effect on various solid and hematological malignancies.

PMID:35399416 | PMC:PMC8980239 | DOI:10.7759/cureus.22825